Application of Machine Learning to Metabolomic Profile Characterization in Glioblastoma Patients Undergoing Concurrent Chemoradiation
Orwa Aboud(University of California, Davis), Orin Bloch(Neurological Surgery), Yin Liu(Janssen (United States)), Christopher R. Brydges(Duke University), Jonathan W. Riess(University of California Davis Medical Center), Oliver Fiehn(University of California, Davis), Han Sung Lee(University of California, Davis), Rubén Fragoso(University of California, Davis), Rawad Hodeify(Weill Cornell Medical College in Qatar)
Cited by 17
Related Papers
Proposed minimum reporting standards for chemical analysis
|Metabolomics|2007|5k
MS-DIAL: data-independent MS/MS deconvolution for comprehensive metabolome analysis
|Nature Methods|2015|3.5k
Non–Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2022|1.4k
Five-Year Outcomes With Pembrolizumab Versus Chemotherapy for Metastatic Non–Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥ 50%
|Journal of Clinical Oncology|2021|1.1k
A lipidome atlas in MS-DIAL 4
|Nature Biotechnology|2020|901